desipramine has been researched along with phenylpropanolamine in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jacques, S; Mangner, TJ; Sherman, P; Sisson, JC; Tobes, MC; Wieland, DM | 1 |
| Lewander, T | 1 |
| Costa, E; Groppetti, A | 1 |
| Hricik, JG; Johnson, DA | 1 |
| Dorne, JL; Renwick, AG; Slob, W; Walton, K | 1 |
5 other study(ies) available for desipramine and phenylpropanolamine
| Article | Year |
|---|---|
Metaiodobenzylguanidine as an index of the adrenergic nervous system integrity and function.
Topics: 3-Iodobenzylguanidine; Adrenergic Fibers; Animals; Desipramine; Female; Heart; Hydroxydopamines; Iodine Radioisotopes; Iodobenzenes; Phenylpropanolamine; Radionuclide Imaging; Rats | 1987 |
Onthe presence of p-hydroxynorephedrine in the rat brain and heart in relation to changes in catecholamine levels after administration of amphetamine.
Topics: Amino Alcohols; Amphetamine; Animals; Brain Chemistry; Desipramine; Male; Myocardium; Norepinephrine; Phenethylamines; Phenylpropanolamine; Rats; Sympathomimetics | 1971 |
Tissue concentrations of p-hydroxynorephedrine in rats injected with d-amphetamine: effect of pretreatment with desipramine.
Topics: Animals; Body Temperature; Brain Chemistry; Desipramine; Dextroamphetamine; Male; Motor Activity; Myocardium; Norepinephrine; Phenylpropanolamine; Rats; Sympathomimetics | 1969 |
Effects of dl-norephedrine and its enantiomers on norepinephrine uptake and release in isolated rat caudal artery.
Topics: Adrenergic Uptake Inhibitors; Animals; Arteries; Desipramine; Dose-Response Relationship, Drug; Male; Neurotransmitter Agents; Norepinephrine; Phenylpropanolamine; Rats; Rats, Sprague-Dawley; Stereoisomerism; Sympathetic Nervous System; Sympathomimetics; Tail; Tritium; Tyramine | 1996 |
Human variability in polymorphic CYP2D6 metabolism: is the kinetic default uncertainty factor adequate?
Topics: Adult; Aged; Aging; Benzhydryl Compounds; Cresols; Cyclohexanols; Cytochrome P-450 CYP2D6; Debrisoquin; Desipramine; Encainide; Ethnicity; Genetic Variation; Humans; Hydroxylation; Infant; Infant, Newborn; Kidney Diseases; Kinetics; Liver Diseases; Metabolic Clearance Rate; Metoprolol; Phenylpropanolamine; Polymorphism, Genetic; Propafenone; Substrate Specificity; Tolterodine Tartrate; Venlafaxine Hydrochloride | 2002 |